(19)
(11) EP 1 235 570 A2

(12)

(88) Date of publication A3:
14.02.2002

(43) Date of publication:
04.09.2002 Bulletin 2002/36

(21) Application number: 00982461.6

(22) Date of filing: 07.12.2000
(51) International Patent Classification (IPC)7A61K 31/40, A61P 25/00
(86) International application number:
PCT/US0033/060
(87) International publication number:
WO 0104/1750 (14.06.2001 Gazette 2001/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.12.1999 US 458607

(71) Applicant: Wyeth
Madison, New Jersey 07940-0874 (US)

(72) Inventor:
  • MARQUIS, Karen, Lovell
    Yardley, PA 19067 (US)

(74) Representative: Wileman, David Francis Dr. 
Wyeth Pharmaceuticals,Huntercombe Lane South,Taplow
Maidenhead,Berkshire SL6 OPH
Maidenhead,Berkshire SL6 OPH (GB)

   


(54) COMBINATIONS OF (S)-2-(BENZYLAMINO-METHYL)-2,3,8,9,-TETRAHYDRO-7H-1,4-DIOXINO(2,3)-E INDOL-8-ONE AND NEUROLEPTICS